A multicentre validation of Metasin: a molecular assay for the intraoperative assessment of sentinel lymph nodes from breast cancer patients

Sai-Giridhar, Priya and Al-Ramadhani, Salma and George, Dilushana and Gopinath, Preethi and Andrews, William and Jader, Samar and Brown, Shelley and Findlay, Alison and Arkoumani, Evdokia and Al-Sam, Salam and McKenzie, Jolanta G and Bradpiece, Howard and Jenkins, Stephanie and Aylwin, Anthony and Holt, Simon and Sharaiha, Yousef and Yiangou, Constantinos and Agrawal, Avi and McDowell, Amanda and Gabriel, Francis G and Jeffrey, Margaret and Agrawal, Neerja and Cree, Ian A and Mansel, Robert E and Keshtgar, Mo and McDermott, Nuala and El Sheikh, Soha and Wellsted, David and Collard, Jade and Chaplin, Hema and Landt, Olfert and Bustin, Stephen A. and Sundaresan, Maryse and Sundaresan, Vasi (2016) A multicentre validation of Metasin: a molecular assay for the intraoperative assessment of sentinel lymph nodes from breast cancer patients. Histopathology, 68 (6). pp. 875-887. ISSN 1365-2559

Published Version
Available under the following license: Creative Commons Attribution Non-commercial No Derivatives.

Download (331kB) | Preview
Official URL: https://doi.org/10.1111/his.12863


Aims: Treatment strategies for breast cancer continue to evolve. No uniformity exists in the UK for the management of node‐positive breast cancer patients. Most centres continue to use conventional histopathology of sampled sentinel lymph nodes (SLNs), which requires delayed axillary clearance in up to 25% of patients. Some use touch imprint cytology or frozen section for intraoperative testing, although both have inherent sensitivity issues. An intraoperative molecular diagnostic approach helps to overcome some of these limitations. The aim of this study was to assess the clinical effectiveness of Metasin, a molecular method for the intraoperative evaluation of SLNs. Methods and results: RNA from 3296 lymph nodes from 1836 patients undergoing SLN assessment was analysed with Metasin. Alternate slices of tissue were examined in parallel by histology. Cases deemed to be discordant were analysed by protein gel electrophoresis. There was concordance between Metasin and histology in 94.1% of cases, with a sensitivity of 92% [95% confidence interval (CI) 88–94%] and a specificity of 97% (95% CI 95–97%). Positive and negative predictive values were 88% and 98%, respectively. Over half of the discordant cases (4.4%) were ascribed to tissue allocation bias (TAB). Conclusions: Clinical validation of the Metasin assay suggests that it is sufficiently sensitive and specific to make it fit for purpose in the intraoperative setting.

Item Type: Journal Article
Keywords: axillary clearance, breast cancer, CK19, intraoperative, mammaglobin, Metasin, molecular, PCR, sensitivity, sentinel lymph node, specificity
Faculty: ARCHIVED Faculty of Medical Science (until September 2018)
Depositing User: Lisa Blanshard
Date Deposited: 25 Feb 2020 11:44
Last Modified: 09 Sep 2021 19:00
URI: https://arro.anglia.ac.uk/id/eprint/705214

Actions (login required)

Edit Item Edit Item